Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esarin Gel in Chronic Venous Insufficiency and Superficial Vein Thrombophlebitis
NCT02346058Phase 4Completed
- Sponsor
- Sun Pharma
- Start
- Oct 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Esarin Gel in chronic venous insufficiency (CVI), Varicose Veins and superficial vein thrombophlebitis (SVT), sponsored by Sun Pharma. Primary endpoints: Change in subject's leg swelling at 28 days and Change in subject's leg pain at 28 days. Started Oct 2013; status: completed.
02
Drugs
Esarin Gel
03
Conditions
chronic venous insufficiency (CVI)Varicose Veinssuperficial vein thrombophlebitis (SVT)
Beyond the preview
Go deeper on NCT02346058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02346058.